165 related articles for article (PubMed ID: 24755315)
1. Vascular measurements correlate with estrogen receptor status.
Lloyd MC; Alfarouk KO; Verduzco D; Bui MM; Gillies RJ; Ibrahim ME; Brown JS; Gatenby RA
BMC Cancer; 2014 Apr; 14():279. PubMed ID: 24755315
[TBL] [Abstract][Full Text] [Related]
2. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer.
Svensson S; Abrahamsson A; Rodriguez GV; Olsson AK; Jensen L; Cao Y; Dabrosin C
Clin Cancer Res; 2015 Aug; 21(16):3794-805. PubMed ID: 25901081
[TBL] [Abstract][Full Text] [Related]
3. Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance.
Gohno T; Seino Y; Hanamura T; Niwa T; Matsumoto M; Yaegashi N; Oba H; Kurosumi M; Takei H; Yamaguchi Y; Hayashi S
Cancer Med; 2012 Dec; 1(3):328-37. PubMed ID: 23342282
[TBL] [Abstract][Full Text] [Related]
4. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
[TBL] [Abstract][Full Text] [Related]
8. Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.
Dong XY; Guo P; Sun X; Li Q; Dong JT
J Biol Chem; 2011 Apr; 286(16):13879-90. PubMed ID: 21367855
[TBL] [Abstract][Full Text] [Related]
9. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces.
Lloyd MC; Cunningham JJ; Bui MM; Gillies RJ; Brown JS; Gatenby RA
Cancer Res; 2016 Jun; 76(11):3136-44. PubMed ID: 27009166
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.
He DX; Wu XL; Lu CX; Gu XT; Zhang GY; Ma X; Liu DQ
Oncol Rep; 2017 Dec; 38(6):3392-3402. PubMed ID: 29039577
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients.
Babayan A; Hannemann J; Spötter J; Müller V; Pantel K; Joosse SA
PLoS One; 2013; 8(9):e75038. PubMed ID: 24058649
[TBL] [Abstract][Full Text] [Related]
12. Stromal estrogen receptor-α promotes tumor growth by normalizing an increased angiogenesis.
Péqueux C; Raymond-Letron I; Blacher S; Boudou F; Adlanmerini M; Fouque MJ; Rochaix P; Noël A; Foidart JM; Krust A; Chambon P; Brouchet L; Arnal JF; Lenfant F
Cancer Res; 2012 Jun; 72(12):3010-9. PubMed ID: 22523036
[TBL] [Abstract][Full Text] [Related]
13. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
15. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
16. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
[TBL] [Abstract][Full Text] [Related]
17. Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.
Berghuis AMS; van Deurzen CHM; Koffijberg H; Terstappen LWMM; Sleijfer S; IJzerman MJ
Breast Cancer Res Treat; 2019 Jun; 175(2):451-458. PubMed ID: 30756285
[TBL] [Abstract][Full Text] [Related]
18. Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.
Ibrahim-Hashim A; Robertson-Tessi M; Enriquez-Navas PM; Damaghi M; Balagurunathan Y; Wojtkowiak JW; Russell S; Yoonseok K; Lloyd MC; Bui MM; Brown JS; Anderson ARA; Gillies RJ; Gatenby RA
Cancer Res; 2017 May; 77(9):2242-2254. PubMed ID: 28249898
[TBL] [Abstract][Full Text] [Related]
19. Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.
Vesuna F; Lisok A; Kimble B; Domek J; Kato Y; van der Groep P; Artemov D; Kowalski J; Carraway H; van Diest P; Raman V
Oncogene; 2012 Jul; 31(27):3223-34. PubMed ID: 22056872
[TBL] [Abstract][Full Text] [Related]
20. Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.
Jeselsohn R; Yelensky R; Buchwalter G; Frampton G; Meric-Bernstam F; Gonzalez-Angulo AM; Ferrer-Lozano J; Perez-Fidalgo JA; Cristofanilli M; Gómez H; Arteaga CL; Giltnane J; Balko JM; Cronin MT; Jarosz M; Sun J; Hawryluk M; Lipson D; Otto G; Ross JS; Dvir A; Soussan-Gutman L; Wolf I; Rubinek T; Gilmore L; Schnitt S; Come SE; Pusztai L; Stephens P; Brown M; Miller VA
Clin Cancer Res; 2014 Apr; 20(7):1757-1767. PubMed ID: 24398047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
